Femasys (FEMY) Shares Outstanding (2020 - 2026)
Femasys' (FEMY) quarterly Shares Outstanding (Entity) came in at $3.0 million in Q2 2026, up 85.66% on a YoY basis from $1.6 million in Q2 2025, and little changed quarter-over-quarter from $3.0 million in Q1 2026.
Analysis
Femasys (FEMY) Shares Outstanding (2020 - 2026) Analysis & Trends
Femasys (FEMY) has reported Shares Outstanding (Entity) for 7 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 85.66% year-over-year to $3.0 million; the trailing twelve-month figure through Jun 2026 stood at $3.0 million (up 85.66% YoY), and the FY2025 full-year result was $2.0 million, up 69.33% from the prior year.
- Shares Outstanding (Entity) held at $3.0 million in Q2 2026 per FEMY's latest filing, from $3.0 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $3.0 million in Q2 2026 and bottomed at $590208.0 in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $1.3 million across 5 years, with a median of $1.1 million in 2024.
- The widest YoY moves for Shares Outstanding (Entity): up 961.11% in 2022, down 0.12% in 2022.
- Over 5 years, Shares Outstanding (Entity) stood at $593485.0 in 2022, then advanced by 29.61% to $769219.0 in 2023, then jumped by 51.82% to $1.2 million in 2024, then soared by 69.33% to $2.0 million in 2025, then surged by 52.92% to $3.0 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $3.0 million, $3.0 million, and $2.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Femasys | 9.01 Mn | 7.57 Mn | 189,391.00 | 3.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.36 Mn |
| Mar 31, 2026 | 3.33 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.11 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 1.11 Mn |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 769,219.00 |
| Sep 30, 2023 | 754,657.00 |
| Jun 30, 2023 | 655,380.00 |
| Mar 31, 2023 | 593,613.00 |
| Dec 31, 2022 | 590,751.00 |
| Sep 30, 2022 | 590,680.00 |
| Jun 30, 2022 | 590,649.00 |
| Mar 31, 2022 | 590,208.00 |
| Dec 31, 2021 | 335,601.00 |
| Sep 30, 2021 | 589,986.00 |